Page last updated: 2024-11-04

rofecoxib and Ulcer

rofecoxib has been researched along with Ulcer in 3 studies

Ulcer: A lesion on the surface of the skin or a mucous surface, produced by the sloughing of inflammatory necrotic tissue.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lugardon, S1
Lapeyre-Mestre, M1
Montastruc, JL1
Calvo, N1
Iversen, E1
Munck, LK1
Murphy, JO1
Ravi, N1
Byrne, PJ1
McDonald, GS1
Reynolds, JV1

Other Studies

3 other studies available for rofecoxib and Ulcer

ArticleYear
Upper gastrointestinal adverse drug reactions and cyclo-oxygenase-2 inhibitors (celecoxib and rofecoxib): a case/non-case study from the French Pharmacovigilance Database.
    European journal of clinical pharmacology, 2004, Volume: 60, Issue:9

    Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Celecoxib; Cyclooxygenase 2; Cyclo

2004
[Intestinal side effects of COX-2 inhibitors].
    Ugeskrift for laeger, 2006, Mar-27, Volume: 168, Issue:13

    Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Colonic Diseases; Colonic Pouches;

2006
Neither antioxidants nor COX-2 inhibition protect against esophageal inflammation in an experimental model of severe reflux.
    The Journal of surgical research, 2007, Volume: 142, Issue:1

    Topics: Animals; Antioxidants; Ascorbic Acid; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug;

2007
chemdatabank.com